A BRISTOL TENNESSEE BASED PHARMACEUTICAL COMPANY IS UPPING ITS OFFER TO PURCHASE ALPHARMA INCORPORATED. OFFICIALS WITH KING PHARMACEUTICALS ARE PROPOSING TEN PERCENT MORE BRINGING THE OFFER TO THIRTY SEVEN DOLLARS PER SHARE. THIS MARKS THE SECOND TIME KING HAS INCREASED ITS OFFER FOR THE BRIDGEWATER NEW JERSEY COMPANY IN THE PAST FOUR WEEKS. KING OFFICIALS SAY THEY WANT TO PURCHASE THE DRUG COMPANY IN ORDER TO USE ITS MARKETING TEAM AND SALES FORCE TO LAUNCH NEW PRODUCTS. ALPHARMA’S BOARD PLANS TO HAVE AN ANSWER FOR KING WITHIN TEN DAYS.